Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abaloparatide in Men With Osteoporosis (ATOM)
NCT03512262Phase 3Completed
- Sponsor
- Radius Health Inc
- Start
- May 2018
- Primary completion
- Aug 2021
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 3 trial of abaloparatide in osteoporosis, sponsored by Radius Health Inc. Started May 2018; status: completed.
02
Drugs
abaloparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03512262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512262.